2.74
0.00 (0.00%)
0.00 (0.00%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Marker Therapeutics Inc | MRKR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 2.74 | 2.71 | 2.82 | 2.75 | 2.74 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.66 | 2.91 | 0.25 | 8.59% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 961 | 216,473 | $ 2.76 | $ 598,479 | 286,016 | 2.45 - 9.17 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 3,865 | $ 2.74 | USD |
Marker Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 125.28M | 45.72M | $ -147.96M | -7.75 | - | 30.50M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Marker Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRKR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.82 | 2.88 | 2.65 | 2.74 | 172,368 | -0.08 | -2.84% |
| 1 Month | 3.12 | 3.35 | 2.45 | 2.79 | 297,438 | -0.38 | -12.18% |
| 3 Months | 3.10 | 3.45 | 2.45 | 2.99 | 314,526 | -0.36 | -11.61% |
| 6 Months | 5.51 | 6.54 | 2.45 | 3.65 | 301,177 | -2.77 | -50.27% |
| 1 Year | 6.06 | 9.17 | 2.45 | 5.32 | 403,183 | -3.32 | -54.79% |
| 3 Years | 10.01 | 10.25 | 2.45 | 5.50 | 363,035 | -7.27 | -72.63% |
| 5 Years | 10.01 | 10.25 | 2.45 | 5.50 | 363,035 | -7.27 | -72.63% |
Marker Therapeutics Description
| Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from our MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. |
